Literature DB >> 2192775

Microangiopathy, the vascular basement membrane and Alzheimer's disease: a review.

L S Perlmutter1, H C Chui.   

Abstract

The present review focuses on the vascular basement membrane (VBM) and its relationship to the lesions of Alzheimer's disease (AD). Examination of the fine structure of the microvasculature reveals AD-associated VBM alterations, which include both thickening and vacuolization. Immunocytochemistry confirms that all three intrinsic VBM components [collagen type IV, laminin, and heparan sulfate proteoglycan (HSPG)] outline the capillary bed, which is pathologically altered in AD patients (microangiopathy). Ultrastructural analyses of AD tissue samples demonstrate that HSPG's normal staining pattern is disrupted on the endothelial surface of the VBM in brain regions affected by Alzheimer lesions. Similarly altered VBM is reported to occur in the kidney of patients with diabetes mellitus, where it is associated with a leakage of protein. All three VBM components immunolabel capillaries, amyloid and plaque-associated glial processes, suggesting a link between microangiopathy and senile plaque formation. In addition, the consistent colocalization of HSPG with several forms of amyloid implies an involvement in amyloidogenesis. Finally, the neurotrophic effects of beta-amyloid, combined with neurite-promoting effects of laminin and HSPG, could create a strong focus for an aberrant sprouting response. Such a response is postulated to result in plaque-associated degenerating neurites. Thus, VBM components could serve as a nidus for plaque formation, playing a role in the development of neuritic as well as amyloidotic elements.

Entities:  

Mesh:

Year:  1990        PMID: 2192775     DOI: 10.1016/0361-9230(90)90007-m

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  35 in total

Review 1.  Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: a rationale based on homology between cerebral and retinal microvasculatures.

Authors:  Niall Patton; Tariq Aslam; Thomas Macgillivray; Alison Pattie; Ian J Deary; Baljean Dhillon
Journal:  J Anat       Date:  2005-04       Impact factor: 2.610

2.  Microvascular changes in the white mater in dementia.

Authors:  William R Brown; Dixon M Moody; Clara R Thore; John A Anstrom; Venkata R Challa
Journal:  J Neurol Sci       Date:  2009-03-05       Impact factor: 3.181

Review 3.  Anti-amyloid drugs: potential in the treatment of diseases associated with aging.

Authors:  R Kisilevsky
Journal:  Drugs Aging       Date:  1996-02       Impact factor: 3.923

Review 4.  The vascular basement membrane in the healthy and pathological brain.

Authors:  Maj S Thomsen; Lisa J Routhe; Torben Moos
Journal:  J Cereb Blood Flow Metab       Date:  2017-07-28       Impact factor: 6.200

5.  Dense-core plaques in Tg2576 and PSAPP mouse models of Alzheimer's disease are centered on vessel walls.

Authors:  Samir Kumar-Singh; Daniel Pirici; Eileen McGowan; Sally Serneels; Chantal Ceuterick; John Hardy; Karen Duff; Dennis Dickson; Christine Van Broeckhoven
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

6.  Targeting vascular amyloid in arterioles of Alzheimer disease transgenic mice with amyloid β protein antibody-coated nanoparticles.

Authors:  Joseph F Poduslo; Kristi L Hultman; Geoffry L Curran; Gregory M Preboske; Ryan Chamberlain; Małgorzata Marjańska; Michael Garwood; Clifford R Jack; Thomas M Wengenack
Journal:  J Neuropathol Exp Neurol       Date:  2011-08       Impact factor: 3.685

7.  Immunolabelling of hippocampal microvessel glucose transporter protein is reduced in Alzheimer's disease.

Authors:  N Horwood; D C Davies
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

Review 8.  Proteoglycans and other basement membrane proteins in amyloidoses.

Authors:  R Kisilevsky
Journal:  Mol Neurobiol       Date:  1994 Aug-Dec       Impact factor: 5.590

9.  Polarized secretion of beta-amyloid precursor protein and amyloid beta-peptide in MDCK cells.

Authors:  C Haass; E H Koo; D B Teplow; D J Selkoe
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

10.  Cerebral vascular leak in a mouse model of amyloid neuropathology.

Authors:  Eric A Tanifum; Zbigniew A Starosolski; Stephanie W Fowler; Joanna L Jankowsky; Ananth V Annapragada
Journal:  J Cereb Blood Flow Metab       Date:  2014-07-23       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.